Mega Lifesciences PCL (BKK:MEGA)

Market Cap	26.81B
Revenue (ttm)	14.31B
Net Income (ttm)	1.86B
Shares Out	871.87M
EPS (ttm)	2.14
PE Ratio	14.39
Forward PE	12.39
Dividend	1.60 (5.20%)
Ex-Dividend Date	Aug 27, 2025

Volume	240,919
Average Volume	754,794
Open	30.75
Previous Close	30.75
Day's Range	30.75 - 31.25
52-Week Range	24.30 - 41.25
Beta	0.25
RSI	51.21
Earnings Date	Nov 13, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.